Infection Probability Score: A predictor of Clostridium difficile-associated disease onset in patients with haematological malignancy

被引:17
|
作者
Apostolopoulou, Eleni [2 ]
Raftopoulos, Vasilios [1 ]
Terzis, Konstantinos [3 ]
Elefsiniotis, Ioannis [2 ]
机构
[1] Cyprus Univ Technol, Dept Nursing, Mediterranean Res Ctr Publ Hlth & Qual Care, Nicosia, Cyprus
[2] Univ Athens, Dept Nursing, Athens, Greece
[3] Halkida Gen Hosp, Halkida, Greece
关键词
Infection probability score; Healthcare-associated infections; APACHE II; KARNOFSKY; Hematology; Clostridium difficile-associated disease; RISK-FACTORS; NOSOCOMIAL INFECTIONS; HOSPITALIZED-PATIENTS; APACHE-II; DIARRHEA; TOXIN; EPIDEMIOLOGY; CHEMOTHERAPY; COLITIS; SURVEILLANCE;
D O I
10.1016/j.ejon.2010.11.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: to assess the predictive power of three systems: Infection Probability Score, APACHE II and KARNOFSKY score for the onset of Clostridium difficile-associated disease (CDAD) in hematology-oncology patients. Methods and sample: A retrospective pilot surveillance survey was conducted in the hematology unit of a general hospital in Greece. Data were collected by using an anonymous standardised case-record form. The sample consisted of 102 hospitalized patients. Results: The majority of the patients (33.3%) suffered from acute myeloid leukemia. The cumulative incidence of CDAD was 10.8% and the incidence rate of C difficile associated diarrhea was 5 per 1000 patient-days (14.2 per 1000 patient-days at risk). Patients with CDAD had twofold higher time of mean length of hospital stay compared with patients without CDAD (38.82 +/- 23.88 vs 19.45 +/- 14.56 days). Additionally patients with CDAD had received a greater number of different antibiotics compared to those without CDAD (5.18 +/- 1.99 vs 2.54 +/- 2.13), suffered from diabetes, from non Hodgkin's lymphoma, had a statistically significant higher duration of neutropenia >= 3 days and had received antifungal treatment. The best cutoff value of IPS for the prediction of CDAD was 13 with a sensitivity of 45.5% and a specificity of 82.4%. Conclusions: IPS is an early diagnostic test for CDAD detection. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:404 / 409
页数:6
相关论文
共 50 条
  • [1] Clostridium difficile-Associated Disease Acquired in the Neurocritical Care Unit
    Musa, S. A.
    Robertshaw, H.
    Thomson, S. J.
    Cowan, M. L.
    Rahman, T. M.
    NEUROCRITICAL CARE, 2010, 13 (01) : 87 - 92
  • [2] Clostridium difficile-associated infection: a disease of varying severity
    Jawa, Randeep S.
    Mercer, David W.
    AMERICAN JOURNAL OF SURGERY, 2012, 204 (06) : 836 - 842
  • [3] Clostridium difficile-associated disease among patients in Dhahran, Saudi Arabia
    Al-Tawfiq, Jaffar A.
    Abed, Mahmoud S.
    TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2010, 8 (06) : 373 - 376
  • [4] Infection probability score, APACHE II and KARNOFSKY scoring systems as predictors of infection onset in haematology-oncology patients
    Apostolopolou, Eleni
    Raftopoulos, Vasilios
    Terzis, Konstantinos
    Pissaki, Kiriaki
    Pagoni, Maria
    Delibasi, Sossana
    JOURNAL OF CLINICAL NURSING, 2010, 19 (11-12) : 1560 - 1568
  • [5] Waterlow score to predict patients at risk of developing Clostridium difficile-associated disease
    Tanner, J.
    Khan, D.
    Anthony, D.
    Paton, J.
    JOURNAL OF HOSPITAL INFECTION, 2009, 71 (03) : 239 - 244
  • [6] Clostridium difficile-Associated Disease Acquired in the Cardiothoracic Intensive Care Unit
    Musa, Saif A.
    Moran, Carl
    Thomson, Sam J.
    Cowan, Matthew L.
    McAnulty, Greg
    Grounds, Michael
    Rahman, Tony Manibur
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2011, 25 (02) : 263 - 267
  • [7] Identifying patients at risk of severe Clostridium difficile-associated disease
    Potter, Valerie A.
    Aravinthan, Aloysious
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2012, 73 (05) : 265 - 270
  • [8] Characteristics and incidence of Clostridium difficile-associated disease in The Netherlands, 2005
    Paltansing, S.
    van den Berg, R. J.
    Guseinova, R. A.
    Visser, C. E.
    van der Vorm, E. R.
    Kuijper, E. J.
    CLINICAL MICROBIOLOGY AND INFECTION, 2007, 13 (11) : 1058 - 1064
  • [9] Treatment of Clostridium difficile-Associated Disease
    Leffler, Daniel A.
    Lamont, J. Thomas
    GASTROENTEROLOGY, 2009, 136 (06) : 1899 - 1912
  • [10] The impact of pseudomembrane formation on the outcome of Clostridium difficile-associated disease
    Berdichevski, T.
    Keller, N.
    Rahav, G.
    Bar-Meir, S.
    Eliakim, R.
    Ben-Horin, S.
    INFECTION, 2013, 41 (05) : 969 - 977